Manufacturing Execution System Market

Manufacturing Execution System Market: Industry Trends and Global Forecasts, till 2035 - Type of Deployment (Cloud, Corporate Datacenter, Hybrid and On Premise), Type of End-User (Life science / Biotechnology Companies, Medical Device Providers, Pharmaceutical Companies and Others) and Key Geographical Regions (North America, Europe, Asia, Middle East and North Africa, Latin America, and Rest of the World)

  • Lowest Price Guaranteed From USD 4,799

  • Companies Covered
    113

  • Pages
    119

  • View Count
    12794

Incorporation of MES into production line can streamline material cost and time spent in production. I believe, MES has the potential to reduce 10%-30% of the overall production cost, depending on the type of industry

-- CEO, a small-sized company

Manufacturing Execution System Market Size Overview

The manufacturing execution system market size is estimated to increase from more than $3.9 billion in 2024 to $20.5 billion in 2035, representing a CAGR of 16.3% during the forecast period from 2024 to 2035. The new research study consists of industry trends, detailed market analysis, key market insights, market impact analysis, market forecast and opportunity analysis.

Manufacturing Execution System Market by Type of Deployment (USD Billion)

To learn more about this report, request a free sample copy

According to the American Hospital Association, by 2026, there is likely to be a shortage of 3.2 million healthcare workers. The continuously growing data, coupled to the projected deficit of healthcare workers, would inadvertently generate pressure on healthcare manufacturers to adopt novel tools / technologies that can improve management efficiency and better utilize the available, expensive resources. Moreover, increasing complexity of healthcare manufacturing operations, along with growing stringency and frequent changes in regulatory requirements has created a dire need for adoption of automated solutions, such as manufacturing execution systems (MES).

Pharmaceutical and biologic manufacturing industry is integrating advanced technologies, including internet of thing (IoT) and artificial intelligence (AI), in order to collect and analyze large volume of data from various sources, as well as to produce value in the form of insights, predictions and actions. In January 2024, the FDA issued Quality Management System Regulation (QMSR) Final Rule, which aims to harmonize cGMP requirements with international standards, such as ISO 13485:2016. By leveraging MES solutions, medical device manufacturers can enhance quality control, achieve regulatory compliance, and reduce the financial burden associated with meeting strict FDA regulations. Driven by the ongoing innovation in the biopharmaceutical manufacturing industry, the manufacturing execution system market for the healthcare sector is likely to witness positive market growth over the forecast period.

Manufacturing Execution System Market Scope

The market research report presents an in-depth analysis of the various manufacturing execution system companies, across different segments, as defined in the table below:

Global Manufacturing Execution System Market: Report Attributes / Market Segmentations

Key Report Attribute Details
Historical Trend 2018-2023
Base Year 2023
Forecast Period 2024-2035
Market Size 2035 $20.5 Billion
CAGR 16%
Type of Deployment
  • Cloud
  • Corporate Datacenter
  • Hybrid
  • On Premise
Type of End-User
  • Life science / Biotechnology Companies
  • Medical Device Providers
  • Pharmaceutical Companies
  • Others
Key Geographical Regions
  • North America
  • Europe
  • Asia
  • Middle East and North Africa
  • Latin America
  • Rest of the World
Key Companies Profiled
  • Andea
  • Critical Manufacturing
  • Dassault Systèmes
  • GE Digital
  • Infor
  • Körber
  • Rockwell Automation
(Full list of 110+ companies captured is available in the report)
PowerPoint Presentation
(Complimentary)
Available
Customization Scope 15% Free Customization
Excel Data Packs
(Complimentary)
  • Market Landscape Analysis
  • Partnerships and Collaborations
  • Company Competitiveness Analysis
  • Value Creation Framework
  • Market Forecast and Opportunity Analysis


One of the key objectives of this manufacturing execution system market report was to estimate the current market size, opportunity and the future market growth potential of this domain in pharmaceutical market, over the forecast period. We have provided an informed estimate on the market evolution during the forecast period 2024-2035. The market report also features the likely distribution of the current and forecasted opportunity across various segments, such as type of deployment (cloud, corporate datacentre, hybrid and on premise), type of end-user (life science / biotechnology companies, medical device providers, pharmaceutical companies and others) and key geographical regions (North America, Europe, Asia, Middle East and North Africa, Latin America, and Rest of the World)

The opinions and insights presented in the market research report were also influenced by discussions held with multiple stakeholders in manufacturing execution system market. The market report features detailed transcripts of interviews held with the following individuals:

  • Chief Marketing Officer, UK based Small Company
  • Chief Executive Officer, India based Mid-Sized Company
  • Director of Sales, Israel based Small Company

All actual figures have been sourced and analysed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Manufacturing Execution System Market: Key Insights

The “Manufacturing Execution System Market: Industry Trends and Global Forecasts, till 2035 - Type of Deployment (Cloud, Corporate Datacentre, Hybrid  and On Premise), Type of End-User (Life science / Biotechnology Companies, Medical Device Providers, Pharmaceutical Companies and Others) and Key Geographical Regions (North America, Europe, Asia, Middle East and North Africa, Latin America, and Rest of the World)” market report features an extensive study of the current market landscape, market size, market share, market analysis, market forecast and future opportunities for the manufacturing execution system companies involved in the pharmaceutical market. Key takeaways of the manufacturing execution system market analysis are briefly discussed below.

Competitive Landscape of Manufacturing Execution System Companies

Considering the rising demand for such systems, presently, more than 75 companies claim to offer manufacturing execution systems, based on several deployment models, to the healthcare sector. It is worth mentioning that, in the past few years, substantial acquisition activity has been reported in the manufacturing execution system market, as players strive to become one-stop-shops, to cater to the diverse needs of the healthcare sector. Also, 45% of the manufacturing execution system companies are established in North America.

Global Manufacturing Execution System Market Size

The global manufacturing execution system market is estimated to be worth $3.9 billion in 2024. Driven by the ongoing innovation in the industry, as well as the rise in demand for automated solutions, the manufacturing execution system providers market for the healthcare sector is likely to witness positive market growth at a CAGR of more than 16% during the forecast period.

Segment Analysis: Cloud-Based Manufacturing Execution Systems Are Witnessing Increasing Adoption

It has been observed that companies are increasingly adopting cloud-based manufacturing execution systems, to overcome the challenges associated with growing complexity of processes and global expansion of businesses. Specifically, cloud-based manufacturing execution systems integrate real-time information of different production floors and promote collaboration. In January 2024, Canada based IT Consulting company CGI Group announced collaboration with Korber for leveraging its Werum PAS-X MES Suite to serve its pharmaceutical clients. This MES suite is specifically developed for pharmaceutical and biotechnology industry and is available as either on-premise or cloud-based solution.

Manufacturing Execution System Market Drivers: Cost Saving Potential and Rising Adoption

According to industry experts, manufacturing execution systems have the potential to reduce 10%-30% of the overall production cost depending on the type of industry. In recent years, several healthcare stakeholders have actively undertaken initiatives to incorporate a manufacturing execution system into their production lines, with an aim to connect, monitor and control the complex manufacturing process. Both the contract manufacturing and in-house manufacturing facilities are adopting industry 4.0 technologies. These technologies are allowing digital manufacturing of therapeutics and vaccines.

BioNTech collaborated with Siemens for making its Marburg, Germany facility Industry 4.0 compatible. The facility was one of the main sites for production of its mRNA COVID-19 vaccine. The company adopted Siemens’ Opcenter Execution Pharma solution as the new MES to allow paperless manufacturing.

Key Companies Involved in Manufacturing Execution System Market

Examples of key manufacturing execution system companies (which have also been profiled in this market report; the complete list of companies is available in the full report) include Andea, Critical Manufacturing, Dassault Systèmes, GE Digital, Infor, Körber and Rockwell Automation. This market report includes an easily searchable excel database of all the MES companies, worldwide.

Manufacturing Execution System Market Report Coverage

The market report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this industry, across different geographies. Amongst other elements, the market research report includes:

  • A preface providing an introduction to the full report, Manufacturing Execution System Market: Industry Trends and Global Forecasts, till 2035.
This image highlights the context of Manufacturing Execution Systems Market. Rising complexities related to the increasing data volumes being generated in the healthcare sector, along with the need for visibility, control and synchronization in production processes, has prompted players to integrate manufacturing execution systems This image provides list of Manufacturing Execution System Providers in Healthcare. At present, more than 75 companies across the globe claim to offer manufacturing execution systems (MES) in order to monitor, track and control the production process in the healthcare sector This image presents current market landscape of Manufacturing Execution System Providers in Healthcare. Stakeholders are offering MES, integrated with numerous types of software, through different licensing models to serve the pharmaceutical, life science / biotechnology and medical device industries
  • An outline of the systematic research methodology adopted to conduct the study on manufacturing execution system providing insights on the various assumptions, methodologies, and quality control measures employed to ensure accuracy and reliability of our findings.
  • An executive summary of the key insights captured during our research, offering a high-level view on the current landscape of the manufacturing execution systems and companies their likely evolution in the short to mid and long term.
  • A general introduction to manufacturing execution systems, along with information on their core functions. Additionally, it includes details on the various deployment models adopted by providers. Further, it features a brief discussion on the key advantages and disadvantages associated with manufacturing execution systems in the healthcare sector.
  • A detailed overview of the current market landscape of manufacturing execution system companies in the healthcare industry, along with information on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters (North America, Europe and Asia), type of deployment (cloud, corporate datacenter, hybrid and on premise), integrating MES software (enterprise resource planning, human resource management, manufacturing operation management and product lifecycle management), type of license (perpetual, subscription), type of end-user (life science / biotechnology companies, medical device providers, pharmaceutical companies and others), key features (data integration, document control, performance analysis, production tracking), type of service(s) offered (general support, implementation / upgradation, training) and quality certifications received (ISA-95, ISA-88, ISO 9001, ISO 14001, ISO 13485).
  • An in-depth analysis, highlighting the contemporary manufacturing execution system market trends using five schematic representations, including [A] a vertically grouped bar chart, based on year of establishment and region of headquarters, [B] a horizontally stacked bar chart, based on company size and type of deployment, [C] a waffle chart representation, based on type of license and end-user, [D] a mekko chart representation, based on company size and key features, and [E] a 4D bubble chart comparing the players engaged in manufacturing execution system market, based on several relevant parameters (such as year of establishment, company size, deployment type and quality certifications).
This image highlights the geographical distribution of Manufacturing Execution System Providers in Healthcare. In order to cater to the evolving needs of clients across the world, stakeholders have established presence across different regions; Europe has emerged as the key hub, featuring the highest number of MES providers This image highlights the partnership activity undertaken by players engaged in Manufacturing Execution System. The growing interest of stakeholders is also evident from the rise in partnership activity; in fact, the maximum number of collaborations were inked in 2021 This image highlights competitive analysis of players engaged in the domain of manufacturing execution system. In pursuit of building a competitive edge, manufacturing execution system providers are actively upgrading their existing capabilities to further enhance their respective service / product offerings
  • An analysis of recent partnerships inked between various stakeholders engaged in manufacturing execution system market, during the period 2018-2022, based on several relevant parameters, such as year of partnership, type of partnership model adopted (acquisitions, distribution agreements, service agreements, service alliances, technology integration agreements and technology utilization agreements), type of partner (automation industry, biotechnology, information technology and others), key players (in terms of number of partnerships) and regional distribution.
  • An insightful competitiveness analysis of manufacturing execution system providers in the healthcare industry based on several relevant parameters, such as product portfolio strength (in terms of years of experience of the packaging provider), competitive index (in terms of type of deployment, type of license, type of end-user, key features, type of service(s) offered and quality certifications) and partnership strength (taking into consideration the number of partnerships and type of agreement).
  • Elaborate profiles of key players engaged in the manufacturing execution system industry. Each company profile features a brief overview of the company, along with information on year of establishment, number of employees, location of headquarters and key executives, recent developments and an informed future outlook.
  • An insightful framework depicting the implementation of several advanced tools and technologies, such as artificial intelligence, cloud computing, internet of things and machine learning, in different production stages / functions, which can assist service providers in addressing existing unmet needs. Further, it provides a detailed analysis on ease of implementation and associated risk in integrating above-mentioned technologies, based on the trends highlighted in published literature and patents.
  • A detailed market analysis in order to estimate the existing market size, market value, statistics and future opportunity for manufacturing execution system market during the forecast period. Additionally, the market report features the likely distribution of the current and forecasted opportunity across type of deployment (cloud, corporate datacenter, hybrid and on premise), type of end-user (life science / biotechnology companies, medical device providers, pharmaceutical companies and others), and key geographical regions (North America, Europe, Asia, Middle East and North Africa, Latin America and Rest of the World). In order to account for future uncertainties and add robustness to our forecast model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.
This image describes value creation framework. Our proprietary value creation framework highlights the key tools and technologies that emerging players in this domain must integrate in order to augment their MES portfolio This image highlights the market segments of Manufacturing Execution System Providers Market. The market is expected to witness a healthy growth of over 16% in the coming decade: the opportunity is likely to  be well distributed across various type of deployments, end users and different regions  

Recent Developments in Manufacturing Execution System Market

Several recent developments have taken place in the manufacturing execution system industry, some of which have been outlined below.

  • In November 2023, MasterControl marked a milestone with 150+ customers embracing Manufacturing Excellence, an advanced MES driving digital evolution. Notably, 110 million data captures digitized, averting 7 million GMP errors.
  • In March 2023, Körber entered into a collaboration with TetraScience with an aim to enhance productivity and data integrity for process scale-up and manufacturing operations in biopharma.

Frequently Asked Questions

Question 1: What are manufacturing execution systems (MES)?

Answer: Manufacturing execution systems (MES) are software solutions utilized to track and record transformation of raw materials to finished goods in manufacturing processes.

Question 2: How big is the MES market?

Answer: The manufacturing execution system market / MES market size is estimated to be worth $3.9 billion in 2024.

Question 3: What is the projected manufacturing execution system market growth till 2035?

Answer: The manufacturing execution systems market / MES market is expected to grow at compounded annual growth rate (CAGR) of 16% during the forecast period 2024 - 2035.

Question 4: Who are the leading companies in the manufacturing execution system market?

Answer: Examples of key manufacturing execution system companies (which have also been profiled in this market report; the complete list of companies is available in the full report) include Andea, Critical Manufacturing, Dassault Systèmes, GE Digital, Infor, Körber and Rockwell Automation.

Question 5: How many companies presently claim to offer manufacturing execution system (MES) in healthcare?

Answer: Presently, over 75 companies claim to offer manufacturing execution system (MES) for healthcare globally.

Question 6: Which region is the hub for companies providing manufacturing execution systems (MES)?

Answer: North America presently harbors the majority of the companies providing manufacturing execution systems (MES), with 45% of the companies established in this region.

Question 7: Which type of licensing model is most preferred by companies providing manufacturing execution systems (MES)?

Answer: Presently, over 85% of the manufacturing execution systems (MES) companies offer services via subscription models.

PRICING DETAILS

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print Read more about Single-User License

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple Read more about One Location Site License

This license grants the right of use of the purchased report by a department / team of individuals (up to 12) in a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer Read more about Department License

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the Read more about Enterprise License

Discounts available for multiple report purchases
Click here to send an email to Roots Analysis team. sales@rootsanalysis.com